March 2029 was the promise. The charity's modelling says April 2032
What happened
On 7 October 2026 Cancer Research UK published analysis saying the government is not on track to meet its main cancer waiting time commitment in England. The commitment comes from the National Cancer Plan, published in February 2026. It sets three standards: - 85% of patients start treatment within 62 days of an urgent referral - by March 2029, 80% get a diagnosis or the all-clear within 28 days of an urgent referral for suspected cancer - 96% start treatment within 31 days of a decision to treat The charity's modelling focused on the 62-day standard. It assumed that recent improvements in NHS performance carry on at the same rate. On that path, it says the 85% standard would not be reached until April 2032. That is more than three years after the March 2029 deadline. The model puts performance at 77.8% by March 2029. To close that gap, the charity calculates that around 51,000 more people in England would need to start treatment on time between March 2026 and March 2029 - on top of the improvement already expected. It also says the interim targets for 2027 and 2028 look likely to be missed. Michelle Mitchell, chief executive of Cancer Research UK, said too many people are "anxiously waiting" to start treatment, and that the government "needs to urgently turn up the dial". She added: "Publishing the National Cancer Plan is not a job done."
Why this matters
The 62-day standard is not an abstract number. It measures the stretch of time that patients describe as the hardest part of the whole experience: the gap between being told something might be wrong and actually starting treatment. The clock starts when a patient is urgently referred with suspected cancer. It stops when their first treatment begins. The target has not been met since December 2015. In June 2026, 69.9% of people in England started their first treatment within 62 days. In July 2026 the figure was 71.2%. Both are well below 85%. For many cancers, earlier treatment means better odds. That is the plain reason delays matter. There is a second reason, and it is about behaviour. When people hear that waits are long, some put off going to the GP. That is the opposite of what the evidence supports. Being seen quickly is partly in the system's hands - but getting into the system at all is in yours.
What the evidence actually says
Two things are true at once here, and it is worth holding both. The charity's projection is a model, not a measurement. It assumes recent rates of improvement continue in a straight line. Real health systems rarely move in straight lines. If the measures in the National Cancer Plan work better than the recent trend, the date moves earlier. The Department of Health and Social Care made exactly that point. A spokesperson said the analysis did not account for improvements delivered through the National Cancer Plan, and that performance against all three waiting time standards has improved over the past year. The department added: "we know there is a lot more to do." It also said the National Cancer Board, recently relaunched, will scrutinise progress. That is a fair response. It is also fair to note that the improvement so far, on the charity's figures, is not fast enough to hit the date. The second true thing: performance is genuinely moving in the right direction. The 28-day Faster Diagnosis Standard reached 79.3% in July 2026, against an 80% target. That one is close. So the honest summary is this. Things are getting better. On current speed, they will not get better fast enough to meet a 2029 promise. Whether that changes depends on what happens next, which nobody can model with certainty.
Qurexa perspective
Cancer treatment comes with a long list of medicines. Anti-sickness tablets. Painkillers. Steroids. Drugs to protect the stomach. Often they change from cycle to cycle. We deliver prescriptions across Lincolnshire, and treatment weeks are exactly when a trip to the pharmacy is hardest - because you are tired, because you are immune-suppressed and would rather not sit in a queue, or because someone is driving you to hospital that day anyway. We cannot shorten an NHS waiting list. We can take one errand off a week that already has too much in it. If you or someone you care for is in treatment, ask your pharmacy about delivery - plenty of people do not realise it is an option.
Practical advice
The most useful thing in this whole story is also the simplest: get checked early. Go to your GP if you notice any of these, and they are not normal for you: - a lump anywhere, including the breast, testicle, neck or armpit - a cough, hoarseness or breathlessness lasting three weeks or more - blood in your urine, or in your poo - a change in your bowel habit that lasts a few weeks - unexplained weight loss, or unexplained tiredness that does not lift - a mole that changes shape, size or colour - a sore, ulcer or patch of skin that does not heal - unexplained bleeding after the menopause, or between periods Most of the time these turn out to be something else. That is the point of checking. Ruling cancer out is a good outcome, not a wasted appointment. Two practical notes. First, deciding whether a referral is urgent is the doctor's job - describing your symptoms clearly is yours. Write down when it started and how often it happens before the appointment. Second, if you are offered screening - bowel, breast or cervical - take it. Screening finds cancers before symptoms appear, which is exactly when treatment works best. If you are already in the system and waiting, ask your clinical nurse specialist for the name and number of your point of contact. Having one person to chase makes a real difference.
What to know
On 7 October 2026 Cancer Research UK published modelling suggesting England will not meet its 62-day cancer treatment standard until April 2032 - more than three years after the March 2029 commitment in the National Cancer Plan. The model projects 77.8% of patients starting treatment within 62 days by March 2029, against the 85% target, and says around 51,000 more people would need to start treatment on time over that period to close the gap. The 62-day standard has not been met since December 2015. Performance was 69.9% in June 2026 and 71.2% in July 2026. The 28-day Faster Diagnosis Standard was 79.3% in July, against an 80% target. The Department of Health and Social Care said the analysis did not account for improvements being delivered through the plan, that performance has improved over the past year, and that "we know there is a lot more to do." This is a projection based on recent trends continuing, not a measurement of the future. The practical takeaway does not change: see your GP about symptoms that are new and persistent, and take up screening when it is offered. Sources: Cancer Research UK analysis reported by PA/Mirror, "NHS 'will miss cancer treatment targets by more than three years'", 7 October 2026, https://www.aol.co.uk/articles/nhs-miss-cancer-treatment-targets-230314000.html ; Cancer Research UK, "Cancer waiting times: latest updates and analysis", 13 September 2026, https://news.cancerresearchuk.org/2026/09/13/cancer-waiting-times-latest-updates-and-analysis/ ; Cancer Research UK, "Cancer waiting times", accessed 9 October 2026, https://www.cancerresearchuk.org/about-cancer/worried-about-cancer/cancer-waiting-times This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional.
Related articles
Six hours, not never: the ICU filter notice the MHRA issued today
The UK's medicines and devices regulator has issued a new safety notice to hospitals, and it is about timing. On 13 October 2026 the Medicines and Healthcare p…
Eight pages to a minister: what the data guardian says trust is worth
On 12 October 2026, the government published a letter about who should be trusted with NHS patient data. It was written by Dr Nicola Byrne, the National Data G…
Update: the tests came back, and it was not plague
This is a follow-up to a story we covered on 5 October, when nearly 200 people were being monitored after the death of a laboratory worker in Siberia. There has…